Affiliation:
1. Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, 50134 Florence, Italy
Abstract
Oxidative stress regulates many physiological and pathological processes. Indeed, a low increase in the basal level of reactive oxygen species (ROS) is essential for various cellular functions, including signal transduction, gene expression, cell survival or death, as well as antioxidant capacity. However, if the amount of generated ROS overcomes the antioxidant capacity, excessive ROS results in cellular dysfunctions as a consequence of damage to cellular components, including DNA, lipids and proteins, and may eventually lead to cell death or carcinogenesis. Both in vitro and in vivo investigations have shown that activation of the mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) pathway is frequently involved in oxidative stress-elicited effects. In particular, accumulating evidence identified a prominent role of this pathway in the anti-oxidative response. In this respect, activation of krüppel-like factor 2/4 and nuclear factor erythroid 2-related factor 2 emerged among the most frequent events in ERK5-mediated response to oxidative stress. This review summarizes what is known about the role of the MEK5/ERK5 pathway in the response to oxidative stress in pathophysiological contexts within the cardiovascular, respiratory, lymphohematopoietic, urinary and central nervous systems. The possible beneficial or detrimental effects exerted by the MEK5/ERK5 pathway in the above systems are also discussed.
Funder
Italian Association for Cancer Research
Ente Cassa di Risparmio di Firenze
University of Florence
Reference191 articles.
1. Primary structure of BMK1: A new mammalian map kinase;Lee;Biochem. Biophys. Res. Commun.,1995
2. Components of a new human protein kinase signal transduction pathway;Zhou;J. Biol. Chem.,1995
3. MEK5/ERK5 pathway: The first fifteen years;Drew;Biochim. Biophys. Acta,2012
4. Stecca, B., and Rovida, E. (2019). Impact of ERK5 on the Hallmarks of Cancer. Int. J. Mol. Sci., 20.
5. Paudel, R., Fusi, L., and Schmidt, M. (2021). The MEK5/ERK5 Pathway in Health and Disease. Int. J. Mol. Sci., 22.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献